Association between Gut Microbiota and Breast Cancer: Diet as a Potential Modulating Factor.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
31 Oct 2023
Historique:
received: 06 10 2023
revised: 27 10 2023
accepted: 27 10 2023
medline: 15 11 2023
pubmed: 14 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Breast cancer (BCa) has many well-known risk factors, including age, genetics, lifestyle, and diet; however, the influence of the gut microbiome on BCa remains an emerging area of investigation. This study explores the connection between the gut microbiome, dietary habits, and BCa risk. We enrolled newly diagnosed BCa patients and age-matched cancer-free controls in a case-control study. Comprehensive patient data was collected, including dietary habits assessed through the National Cancer Institute Diet History Questionnaire (DHQ). 16S rRNA amplicon sequencing was used to analyze gut microbiome composition and assess alpha and beta diversity. Microbiome analysis revealed differences in the gut microbiome composition between cases and controls, with reduced microbial diversity in BCa patients. The abundance of three specific microbial genera-Acidaminococus, Tyzzerella, and Hungatella-was enriched in the fecal samples taken from BCa patients. These genera were associated with distinct dietary patterns, revealing significant associations between the presence of these genera in the microbiome and specific HEI2015 components, such as vegetables and dairy for Hungatella, and whole fruits for Acidaminococus. Demographic characteristics were well-balanced between groups, with a significantly higher body mass index and lower physical activity observed in cases, underscoring the role of weight management in BCa risk. Associations between significant microbial genera identified from BCa cases and dietary intakes were identified, which highlights the potential of the gut microbiome as a source of biomarkers for BCa risk assessment. This study calls attention to the complex interplay between the gut microbiome, lifestyle factors including diet, and BCa risk.

Identifiants

pubmed: 37960281
pii: nu15214628
doi: 10.3390/nu15214628
pmc: PMC10649662
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD043488
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA069533
Pays : United States

Références

Front Oncol. 2022 Sep 15;12:961970
pubmed: 36185316
Med Care. 1996 Mar;34(3):220-33
pubmed: 8628042
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Cancers (Basel). 2021 Jun 23;13(13):
pubmed: 34201776
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Front Cell Neurosci. 2015 Oct 14;9:392
pubmed: 26528128
Int J Cancer. 2021 Jun 1;148(11):2712-2723
pubmed: 33460452
Ecol Lett. 2013 Aug;16(8):951-63
pubmed: 23809147
Heliyon. 2022 Dec 13;8(12):e12267
pubmed: 36578408
Cancers (Basel). 2023 Jan 14;15(2):
pubmed: 36672469
Br J Cancer. 2020 Mar;122(5):726-732
pubmed: 31919405
J Transl Med. 2017 Apr 8;15(1):73
pubmed: 28388917
Mol Biol Rep. 2022 Oct;49(10):10023-10037
pubmed: 35733061
Value Health. 2019 Jan;22(1):104-128
pubmed: 30661625
Cell Res. 2020 Jun;30(6):492-506
pubmed: 32433595
J Natl Cancer Inst. 2015 Jun 01;107(8):
pubmed: 26032724
Perm J. 2020;24:
pubmed: 32589577
Microbiome. 2020 Jul 16;8(1):108
pubmed: 32678024
J Acad Nutr Diet. 2018 Sep;118(9):1622-1633
pubmed: 30146073
Int J Environ Res Public Health. 2018 Aug 14;15(8):
pubmed: 30110974
Cell. 2015 Oct 22;163(3):759-71
pubmed: 26422227
Cureus. 2022 Dec 8;14(12):e32309
pubmed: 36628036
Metabolism. 1992 Feb;41(2):135-6
pubmed: 1736035
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
J Immunother Cancer. 2022 Jul;10(7):
pubmed: 35882448
Cancer Immunol Res. 2022 Nov 2;10(11):1309-1325
pubmed: 36040846
Adv Nutr. 2021 Jun 1;12(3):809-849
pubmed: 33271590
Microorganisms. 2019 Jan 10;7(1):
pubmed: 30634578
Nutrients. 2022 Jun 29;14(13):
pubmed: 35807903
Exp Mol Med. 2021 Oct;53(10):1636-1646
pubmed: 34707191
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4516-22
pubmed: 20534432
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Cell. 2014 Mar 27;157(1):121-41
pubmed: 24679531
Front Oncol. 2020 Feb 12;10:120
pubmed: 32117767
Circ Res. 2016 Sep 30;119(8):956-64
pubmed: 27507222
Appl Environ Microbiol. 2022 Nov 22;88(22):e0154622
pubmed: 36342199
J Clin Neurol. 2021 Oct;17(4):503-515
pubmed: 34595858
CA Cancer J Clin. 2022 Nov;72(6):524-541
pubmed: 36190501
Cells. 2020 Apr 28;9(5):
pubmed: 32354130
Curr Opin Gastroenterol. 2015 Jan;31(1):69-75
pubmed: 25394236
BMC Cancer. 2022 Mar 31;22(1):353
pubmed: 35361153
Microbiome. 2017 Nov 9;5(1):147
pubmed: 29122007
Nutrients. 2021 Aug 05;13(8):
pubmed: 34444865
Cell Metab. 2021 May 4;33(5):988-1000.e7
pubmed: 33761313
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Cureus. 2021 Aug 26;13(8):e17472
pubmed: 34513524
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Nat Rev Cancer. 2020 Aug;20(8):417-436
pubmed: 32528185
Int J Mol Sci. 2022 Aug 22;23(16):
pubmed: 36012771
Eur J Nutr. 2020 Aug;59(5):1845-1858
pubmed: 31273523
Microb Ecol Health Dis. 2015 Feb 02;26:26191
pubmed: 25651997
Microorganisms. 2022 Oct 17;10(10):
pubmed: 36296324
Alcohol Alcohol. 2020 Apr 16;55(3):246-253
pubmed: 32090238
Breast Cancer Res Treat. 2020 Jul;182(2):451-463
pubmed: 32468338
Breast Cancer Res. 2020 Jan 13;22(1):5
pubmed: 31931881

Auteurs

Duygu Altinok Dindar (D)

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

Brie Chun (B)

Division of Hematology & Oncology, Oregon Health & Science University, Portland, OR 97239, USA.

Amy Palma (A)

Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97239, USA.

John Cheney (J)

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

Madeline Krieger (M)

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

Kristin Kasschau (K)

Department of Microbiology, Department of Statistics, Center for Quantitative Life Sciences, Oregon State University, Corvallis, OR 97331, USA.

Keaton Stagaman (K)

Department of Microbiology, Department of Statistics, Center for Quantitative Life Sciences, Oregon State University, Corvallis, OR 97331, USA.

Zahi I Mitri (ZI)

British Columbia Cancer, Vancouver, BC V5Z 4E6, Canada.

Shaun M Goodyear (SM)

Division of Hematology & Oncology, Oregon Health & Science University, Portland, OR 97239, USA.

Jackilen Shannon (J)

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97239, USA.

Lisa Karstens (L)

Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR 97239, USA.
Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR 97239, USA.

Thomas Sharpton (T)

Department of Microbiology, Department of Statistics, Center for Quantitative Life Sciences, Oregon State University, Corvallis, OR 97331, USA.

Zhenzhen Zhang (Z)

Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97239, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH